A large animal study has shown that certain microsecond electrical pulses can punch nanoscale holes in the membranes of target cells without harming tissue scaffolding, including that in the blood vessels – a potential breakthrough in minimally invasive surgical treatments of tumors.
A three-fold rate of severe complications overall is reported among women having a planned cesarean section compared with those who planned a vaginal delivery.
Boston Scientific Corporation (NYSE: BSX) today welcomed the online release of several important articles scheduled for publication in the March 8th edition of the New England Journal of Medicine (NEJM).
Boston Scientific Corporation (NYSE: BSX) today commented on results from a Swedish registry assessing the long-term outcomes of drug-eluting stents (DES) versus bare- metal stents (BMS) that were released online today and are scheduled for publication in the March 8th edition of the New England Journal of Medicine.
The long-term safety of the CYPHER(R) Sirolimus-eluting Coronary Stent, specifically in terms of death, myocardial infarction (heart attacks) and stent thrombosis (also known as blood clots), is comparable to that of bare metal stents when used according to product labeling, according to a variety of studies appearing today in the New England Journal of Medicine (NEJM).
Using a nuclear transfer procedure, scientists at Rockefeller University and the Howard Hughes Medical Institute have, for the first time, shown reproducibly that mice can be cloned from adult stem cells.
In a randomized placebo-controlled trial, patients smoking cannabis experienced a 34 percent reduction in intense foot pain associated with HIV — twice the rate experienced by patients who smoked placebo.
In a new large, prospective study, researchers found that midday napping — siestas — reduced coronary mortality by about one-third among men and women.
The U.S. Food and Drug Administration (FDA) today announced it has cleared for marketing in the U.S. the TephaFLEX Absorbable Suture?the first absorbable polymer suture made from material isolated from bacteria modified by recombinant DNA technology.
New research published in the February issue of CHEST, the peer-reviewed journal of the American College of Chest Physicians (ACCP), suggests that high-risk smokers with acute cardiovascular disease are three to four times more likely to quit smoking when treated with an intensive smoking cessation program.